Denali Therapeutics (DNLI) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free DNLI Stock Alerts $15.43 +0.47 (+3.14%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDenali Therapeutics (NASDAQ:DNLI) Hits New 52-Week Low at $14.56marketbeat.com - April 25 at 3:44 PMOversold Conditions For Denali Therapeutics (DNLI)nasdaq.com - April 20 at 9:22 PMVicki L. Sato Sells 1,666 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) Stockinsidertrades.com - April 19 at 5:44 AMDenali Therapeutics Inc. (NASDAQ:DNLI) Director Sells $30,471.14 in Stockmarketbeat.com - April 17 at 6:51 PMDenali Therapeutics (DNLI) Price Target Decreased by 5.45% to 42.01msn.com - April 17 at 1:04 PMDenali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Nisa Investment Advisors LLCmarketbeat.com - April 15 at 5:18 AMDenali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of "Buy" from Brokeragesmarketbeat.com - April 10 at 2:29 AMDenali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Baillie Gifford & Co.marketbeat.com - April 9 at 12:12 PMDenali Therapeutics (NASDAQ:DNLI) Price Target Cut to $32.00 by Analysts at UBS Groupmarketbeat.com - April 9 at 12:12 PMFlagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciencestmcnet.com - April 8 at 12:26 PMDenali Therapeutics Inc. (NASDAQ:DNLI) Director Steve E. Krognes Sells 92,500 Sharesinsidertrades.com - April 3 at 4:56 AMInsider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Director Sells 92,500 Shares of Stockmarketbeat.com - April 2 at 9:27 PMVanguard Group Inc. Buys 354,798 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)marketbeat.com - March 31 at 4:07 AMDenali Therapeutics files to sell 29.29M shares of common stock for holdersmsn.com - March 22 at 6:17 PMFurther weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%finance.yahoo.com - March 19 at 8:31 AMZacks Research Comments on Denali Therapeutics Inc.'s FY2026 Earnings (NASDAQ:DNLI)marketbeat.com - March 19 at 7:30 AMWellington Management Group LLP Acquires 250,784 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)marketbeat.com - March 17 at 4:47 AMDNLI Apr 2024 12.500 putfinance.yahoo.com - March 17 at 1:23 AMDNLI Apr 2024 10.000 callfinance.yahoo.com - March 16 at 5:20 AMDNLI Apr 2024 17.500 putfinance.yahoo.com - March 16 at 5:20 AMDenali Therapeutics Inc. (NASDAQ:DNLI) Shares Acquired by Eventide Asset Management LLCmarketbeat.com - March 1 at 9:33 AMDenali Therapeutics Inc. Expected to Post FY2024 Earnings of ($2.70) Per Share (NASDAQ:DNLI)marketbeat.com - March 1 at 8:28 AMStrong Growth and Value Potential Justify Buy Rating for Denali Therapeutics Despite Dilutionmarkets.businessinsider.com - March 1 at 6:24 AMGoldman Sachs Maintains Buy Rating for Denali Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - February 29 at 12:39 PMDenali Therapeutics Inc. Forecasted to Post Q3 2024 Earnings of ($0.58) Per Share (NASDAQ:DNLI)marketbeat.com - February 29 at 8:40 AMBuy Rating Affirmed on Denali Therapeutics Amid Promising DNL310 Progress and ETV Technology Potentialmarkets.businessinsider.com - February 29 at 2:38 AMStrong Buy Rating for Denali Therapeutics: Financial Stability and Promising Clinical Advancementsmarkets.businessinsider.com - February 28 at 9:37 PMBuy Rating Affirmed for Denali Therapeutics on Strong Pipeline and Extended Cash Runwaymarkets.businessinsider.com - February 28 at 4:37 PM4 Analysts Assess Denali Therapeutics: What You Need To Knowmarkets.businessinsider.com - February 28 at 4:37 PMDenali Therapeutics Shares Rise 19% After $500M Financingmarketwatch.com - February 28 at 11:36 AMDenali Therapeutics (NASDAQ:DNLI) Trading Down 9.2% After Earnings Missmarketbeat.com - February 28 at 10:47 AMDenali Therapeutics (NASDAQ:DNLI) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPSmarketbeat.com - February 28 at 10:27 AMDenali Therapeutics (NASDAQ:DNLI) Stock Rating Reaffirmed by Wedbushmarketbeat.com - February 28 at 8:21 AMAnalysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Denali Therapeutics (DNLI)markets.businessinsider.com - February 27 at 5:40 PMDenali Therapeutics Inc.: Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlightsfinanznachrichten.de - February 27 at 12:40 PMCalidi Biotherapeutics, Minerva Neurosciences and Janux among healthcare moversmsn.com - February 27 at 12:40 PMDenali spikes after $500M private placementmsn.com - February 27 at 12:40 PMDenali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Resultsfinance.yahoo.com - February 27 at 12:40 PMDenali Therapeutics (NASDAQ:DNLI) Shares Gap Up to $16.89marketbeat.com - February 27 at 11:47 AMDenali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlightsglobenewswire.com - February 27 at 8:05 AMDenali Therapeutics Announces $500 million Private Placement Equity Financingglobenewswire.com - February 27 at 8:00 AMFederated Hermes Inc. Has $27.89 Million Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)marketbeat.com - February 24 at 7:49 AMBuy Rating on Denali Therapeutics: Anticipating Accelerated FDA Approval with CSF HS Biomarker Breakthroughmarkets.businessinsider.com - February 23 at 4:01 PMBuy Rating Affirmed for Denali Therapeutics Amid Favorable Biomarker-Based Approval Prospectsmarkets.businessinsider.com - February 22 at 12:48 PMDenali Therapeutics (NASDAQ:DNLI) Receives "Buy" Rating from HC Wainwrightmarketbeat.com - February 22 at 8:26 AMCitigroup Inc. Grows Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)marketbeat.com - February 22 at 5:24 AMDenali Therapeutics Inc. (NASDAQ:DNLI) Given Average Recommendation of "Buy" by Brokeragesmarketbeat.com - February 20 at 1:36 AMDenali Therapeutics price target lowered by $5 at Citi, here's whyrealmoney.thestreet.com - February 17 at 10:35 AMDNLI Mar 2024 12.500 callfinance.yahoo.com - February 16 at 11:24 PMDNLI Mar 2024 25.000 putfinance.yahoo.com - February 16 at 11:24 PM Get Denali Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. DNLI Media Mentions By Week DNLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNLI News Sentiment▼-0.490.32▲Average Medical News Sentiment DNLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNLI Articles This Week▼23▲DNLI Articles Average Week Get Denali Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CG Oncology News Today Vericel News Today Immunocore News Today Beam Therapeutics News Today Kymera Therapeutics News Today Ginkgo Bioworks News Today Arcellx News Today Apogee Therapeutics News Today Sana Biotechnology News Today Fusion Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DNLI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Denali Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
